Where competition is heating up in pharma
PharmaVOICE
by Meagan Parrish
2d ago
The stage is set for potential blockbuster-level showdowns targeting these three indications ..read more
Visit website
AstraZeneca’s $80B sales goal by 2030 reflects industry’s penchant for long-term bets
PharmaVOICE
by Michael Gibney
3d ago
Promises made by pharma and biotech companies show confidence in the future of their business and dedication to financial success, R&D and environmental protection ..read more
Visit website
Drug shortages, cost concerns and iffy access — how DTC and telehealth could even the playing field
PharmaVOICE
by Michael Gibney
4d ago
Companies like UpScriptHealth led the charge with online prescriptions decades ago, and now the industry is catching on to solve some of healthcare’s most pressing issues ..read more
Visit website
Pfizer and Lilly are elbowing into the direct-to-consumer market. Will it work?
PharmaVOICE
by Amy Baxter
4d ago
Direct-to-consumer platforms offer consumers an online path to sourcing popular medications, but some therapeutic areas may be better suited for the business model.   ..read more
Visit website
3 up-and-coming US biotech hotspots
PharmaVOICE
by Alexandra Pecci
5d ago
These three U.S. cities are putting themselves on the biotech map as unsung hubs of the industry ..read more
Visit website
After Vyvanse patent loss, Takeda’s neuroscience division looks to enter a new era
PharmaVOICE
by Alexandra Pecci
5d ago
Heather Dean discusses the company’s neuroscience pipeline in epilepsy and narcolepsy and moving from a mass market to a rare disease mentality ..read more
Visit website
Why AlphaFold 3 is stirring up so much buzz in pharma
PharmaVOICE
by Kelly Bilodeau
6d ago
The “Nobel Prize-worthy invention” could be worth hundreds of billions commercially — and have a deep impact on drug R&D ..read more
Visit website
Execs from Bayer, Kite and Orca sound off on their launch strategies for cell and gene therapies
PharmaVOICE
by Amy Baxter
6d ago
Planning early, staying nimble and approaching commercialization as a team sport should be top priorities, the leaders said.  ..read more
Visit website
Why H5N1 has scientists and regulators on edge
PharmaVOICE
by Meagan Parrish
1w ago
While the H5N1 threat to humans is still low, the recent influenza outbreak in cattle is presenting strange and challenging hurdles for containment ..read more
Visit website
Investors put $400M into biotech licensing obesity drugs from China
PharmaVOICE
by Gwendolyn Wu
1w ago
The biotech, tentatively named Hercules CM Newco, has rights to three incretin drugs discovered by Jiangsu Hengrui Pharmaceuticals, two of which are in clinical testing ..read more
Visit website

Follow PharmaVOICE on FeedSpot

Continue with Google
Continue with Apple
OR